PURCHASE, N.Y.--June 13, 2002--Nutrition 21 (NXXI):
Expert panel concludes that Chromax(R) chromium picolinate is safe for use in nutritional bars and beverages
Gail Montgomery, President and CEO of Nutrition 21 announced today that the company's Chromax(R) chromium picolinate, already widely used in dietary supplements, is now GRAS (generally recognized as safe), and can be used in foods such as nutrition bars and beverages.
An independent panel of experts approved Chromax as GRAS after careful review of an extensive dossier of safety data that was compiled by ENVIRON, a pre-eminent science and regulatory consultant group.
"This new GRAS status now enables Nutrition 21 to generate incremental revenue by entering the rapidly growing $18 billion functional food & beverage market. Chromax is the perfect nutrient to formulate into products positioned to address many of the health and lifestyle issues that are of increasing concern to the American population, such as weight management, carbohydrate metabolism and cardiovascular health," said Ms. Montgomery.
"Our research indicates a rising consumer demand for food and beverage products with added nutritional benefits. However, food companies have indicated that their product development options are limited by the scarcity of functional ingredients which are generally recognized as safe and which have demonstrated clinical benefits. Chromax, with its proven health benefits, is perfectly suited to address both consumer and food industry needs," she concluded.
About Nutrition 21
Nutrition 21 is a leading developer and marketer of nutritional products whose health benefits are substantiated by clinical research. The Company is the market leader in nutritional chromium, and currently holds 35 patents for nutrition products, 22 of which are for chromium compounds and their uses. Visit www.nutrition21.com.
Safe Harbor Provision
The words "believe", "expect", "anticipate" and other similar expressions generally identify forward-looking statements. Forward-looking statements are based on the company's current expectations and are subject to market, competitive and regulatory factors and the other risks and uncertainties indicated from time to time in the company's filings with the Securities and Exchange Commission. Actual results can differ materially. The company makes no commitment to disclose any revisions to forward-looking statements.